Combatting COVID-19 – The Commitment to One Billion Vaccines
Experts agree that vaccines are sorely needed to end the COVID-19 pandemic, and we are going to need hundreds of millions of doses. Johnson & Johnson together with multiple partners including Beth Israel Deaconess Medical Center (BIDMC) and BARDA* are working to develop a vaccine based on adenovirus vector technology and have committed to supply one billion doses.
But we cannot afford to bet on one horse. Fortunately, there are many vaccine candidates in development. To save lives, it is essential that innovators work together and share their knowledge and experience.
Join Dan Barouch from BIDMC and Hanneke Schuitemaker from the Janssen Pharmaceutical Companies of Johnson & Johnson for a discussion on what could be key success factors for the development of safe and effective vaccines, and for producing them in the immense quantities that are needed.
*The Janssen COVID-19 Vaccine project has been funded in part with Federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under Agreement Number HHSO100201700018Cs.
The information on this webpage, including in the videos, is proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies (“JJI”) and is for informational purposes only. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of Johnson & Johnson or its affiliates. The information presented in the videos is specific and applicable to region in which the original presentation took place. Many videos contain information from, or sessions given by, third parties. Please note that only those third parties that provide this information are responsible for it. By providing this information, JJI does not endorse these third parties or any of the information provided in these videos, and JJI makes no representations, warranties, or assurances, express or implied, as to the content or the information presented and is not responsible for any use of this information by you.